Inactive Instrument
Kite Pharma Inc Share Price
Equities
US49803L1098
Biotechnology & Medical Research
More press releases
More news
| Manager | Title | Age | Since |
|---|---|---|---|
Shelby Geyer
DFI | Director of Finance/CFO | - | 31/08/2023 |
Priti Hegde
CTO | Chief Tech/Sci/R&D Officer | 53 | 30/09/2023 |
Joe Spiegler
LAW | General Counsel | - | 30/09/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.89% | -1.00% | -50.59% | -11.63% | 54.27B | ||
| +0.08% | -6.56% | +32.96% | +42.96% | 33.25B | ||
| -1.17% | -0.18% | +52.67% | -32.36% | 26.24B | ||
| -0.43% | -0.89% | +21.15% | -16.48% | 25.71B | ||
| -0.82% | +1.51% | +51.66% | +435.31% | 18.89B | ||
| +1.46% | +2.86% | +153.65% | +1,954.89% | 14.97B | ||
| -1.02% | -5.56% | -22.52% | -29.42% | 13.49B | ||
| -3.02% | -9.57% | +106.34% | -64.03% | 12.88B | ||
| -1.45% | -1.63% | +89.03% | +119.59% | 11.11B | ||
| Average | -0.61% | -3.23% | +48.26% | +266.54% | 23.42B | |
| Weighted average by Cap. | -0.25% | -3.13% | +26.60% | +176.10% |
